Arrowpoint Investment Partners Singapore Pte. Ltd. purchased a new stake in Affirm Holdings, Inc. (NASDAQ:AFRM – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 45,850 shares of the company’s stock, valued at approximately $2,792,000. Affirm makes up about 0.6% of Arrowpoint Investment Partners Singapore Pte. Ltd.’s portfolio, making the stock its 13th biggest holding.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in AFRM. Itau Unibanco Holding S.A. bought a new stake in Affirm in the 4th quarter worth about $28,000. Geneos Wealth Management Inc. boosted its stake in shares of Affirm by 356.5% in the 4th quarter. Geneos Wealth Management Inc. now owns 525 shares of the company’s stock worth $32,000 after buying an additional 410 shares during the last quarter. R Squared Ltd bought a new position in shares of Affirm in the fourth quarter valued at approximately $33,000. Coppell Advisory Solutions LLC bought a new position in shares of Affirm in the fourth quarter valued at approximately $40,000. Finally, Strategic Investment Solutions Inc. IL purchased a new stake in shares of Affirm during the fourth quarter valued at approximately $43,000. 69.29% of the stock is owned by institutional investors.
Insiders Place Their Bets
In other Affirm news, Director Keith Rabois sold 16,088 shares of the firm’s stock in a transaction dated Tuesday, April 1st. The stock was sold at an average price of $45.41, for a total value of $730,556.08. Following the transaction, the director now directly owns 45,432 shares of the company’s stock, valued at approximately $2,063,067.12. This trade represents a 26.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Noel Bertram Watson sold 2,500 shares of Affirm stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $45.78, for a total value of $114,450.00. Following the sale, the director now directly owns 38,997 shares in the company, valued at $1,785,282.66. This trade represents a 6.02% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 50,765 shares of company stock valued at $2,694,694. Insiders own 12.41% of the company’s stock.
Analyst Upgrades and Downgrades
View Our Latest Research Report on AFRM
Affirm Trading Down 3.8%
Shares of AFRM opened at $49.74 on Wednesday. The business’s 50-day moving average price is $46.77 and its 200-day moving average price is $57.19. The company has a quick ratio of 11.26, a current ratio of 11.26 and a debt-to-equity ratio of 2.68. Affirm Holdings, Inc. has a twelve month low of $22.25 and a twelve month high of $82.53. The stock has a market cap of $16.05 billion, a PE ratio of -76.52 and a beta of 3.66.
Affirm (NASDAQ:AFRM – Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.01 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.10. Affirm had a negative net margin of 7.10% and a negative return on equity of 7.25%. The business had revenue of $783.14 million for the quarter, compared to analyst estimates of $782.98 million. During the same quarter in the prior year, the firm posted ($0.43) EPS. Affirm’s revenue was up 35.9% on a year-over-year basis. On average, equities analysts forecast that Affirm Holdings, Inc. will post -0.18 EPS for the current fiscal year.
About Affirm
Affirm Holdings, Inc operates a platform for digital and mobile-first commerce in the United States, Canada, and internationally. The company's platform includes point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. Its commerce platform, agreements with originating banks, and capital markets partners enables consumers to pay for a purchase over time with terms ranging up to 60 months.
Read More
- Five stocks we like better than Affirm
- What Is WallStreetBets and What Stocks Are They Targeting?
- Best Utilities Stocks for Stability and Growth in 2025
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Qualcomm’s Re-Entry Into the CPU Market May Not Be Enough
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Applied Digital’s Strategic AI Play Gains Momentum
Receive News & Ratings for Affirm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Affirm and related companies with MarketBeat.com's FREE daily email newsletter.